SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-09-005026
Filing Date
2009-12-22
Accepted
2009-12-22 17:25:14
Documents
2
Period of Report
2009-12-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_35625.htm 8-K 10746
2 EX-99.1 exhibit1.htm EX-99.1 32615
  Complete submission text file 0001299933-09-005026.txt   44823
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 091256158
SIC: 2836 Biological Products, (No Diagnostic Substances)